Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion

Journal of Immunology

Volumn 185, Issue 10, 2010, Pages 6348-6354

  Ye, Zhi Jian ^a   Zhou, Qiong ^a   Gu, Yong Yao ^a,b   Qin, Shou Ming ^b   Ma, Wan Li ^a   Xin, Jian Bao ^a   Tao, Xiao Nan ^a   Shi, Huan Zhong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; GAMMA INTERFERON; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CELL ISOLATION; CELL LINE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IN VITRO STUDY; LUNG CANCER; LYMPHOCYTE DIFFERENTIATION; MALE; PHENOTYPE; PLEURA EFFUSION; PRIORITY JOURNAL; SURVIVAL; TH1 CELL; TH17 CELL;

ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; CELL SEPARATION; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; TH1 CELLS; TH17 CELLS;

EID: 78650636066     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001728     Document Type: Article

References (38)

1. Light, R. W. 2002. Clinical practice: pleural effusion. N. Engl. J. Med. 346:1971-1977.
2. American Thoracic Society. 2000. Management of malignant pleural effusions. Am. J. Respir. Crit. Care Med. 162:1987-2001.
3. Dalbeth, N., and Y. C. Lee. 2005. Lymphocytes in pleural disease. Curr. Opin. Pulm. Med. 11:334-339.
4. Yang, H. B., and H. Z. Shi. 2008. T lymphocytes in pleural effusion. Chin. Med. J. 121:579-580.
5. Rouvier, E., M. F. Luciani, M. G. Mattéi, F. Denizot, and P. Golstein. 1993. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 150:5445-5456.
6. Yao, Z., S. L. Painter, W. C. Fanslow, D. Ulrich, B. M. Macduff, M. K. Spriggs, and R. J. Armitage. 1995. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155:5483-5486.
7. Kawaguchi, M., L. F. Onuchic, X. D. Li, D. M. Essayan, J. Schroeder, H. Q. Xiao, M. C. Liu, G. Krishnaswamy, G. Germino, and S. K. Huang. 2001. Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J. Immunol. 167:4430-4435.
8. H17 and regulatory T cells. Nature 441:235-238.
9. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189.
10. H17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8:337-348.
11. + T helper cells. Cell 126:1121-1133.
12. Kryczek, I., S. Wei, L. Zou, S. Altuwaijri, W. Szeliga, J. Kolls, A. Chang, and W. Zou. 2007. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J. Immunol. 178:6730-6733.
13. H17 and Treg skewing. Clin. Cancer Res. 14:3254-3261.
14. + IL-17-producing T cells in ovarian cancer. Proc. Natl. Acad. Sci. USA 105:15505-15510.
15. Kryczek, I., M. Banerjee, P. Cheng, L. Vatan, W. Szeliga, S. Wei, E. Huang, E. Finlayson, D. Simeone, T. H. Welling, et al. 2009. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114:1141-1149.
16. Moser, B., and P. Loetscher. 2001. Lymphocyte traffic control by chemokines. Nat. Immunol. 2:123-128.
17. Qin, X. J., H. Z. Shi, J. M. Deng, Q. L. Liang, J. Jiang, Z. J. Ye, J. M. Deng, and Z. J. Ye. 2009. CCL22 recruits CD4-positive CD25-positive regulatory T cells into malignant pleural effusion. Clin. Cancer Res. 15:2231-2237.
18. Lucivero, G., G. Pierucci, and L. Bonomo. 1988. Lymphocyte subsets in peripheral blood and pleural fluid. Eur. Respir. J. 1:337-340.
19. Takahashi, K., S. Sone, S. Kimura, T. Ogura, and Y. Monden. 1993. Phenotypes and lymphokine-activated killer activity of pleural cavity lymphocytes of lung cancer patients without malignant effusion. Chest 103:1732-1738.
20. + lymphocytes in pleural cavity of patients with nonsmall cell lung cancer. Thorax 56:639-642.
21. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787-793.
22. Romagnani, S. 1997. The Th1/Th2 paradigm. Immunol. Today 18:263-266.
23. Sakaguchi, S., and N. Sakaguchi. 2005. Regulatory T cells in immunologic selftolerance and autoimmune disease. Int. Rev. Immunol. 24:211-226.
24. Bettelli, E., T. Korn, and V. K. Kuchroo. 2007. Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol. 19:652-657.
25. Steinman, L. 2007. A brief history of T (H) 17, the first major revision in the T (H) 1/T (H) 2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13:139-145.
26. Ikeda, H., K. Chamoto, T. Tsuji, Y. Suzuki, D. Wakita, T. Takeshima, and T. Nishimura. 2004. The critical role of type-1 innate and acquired immunity in tumor immunotherapy. Cancer Sci. 95:697-703.
27. Atanackovic, D., A. Block, A. de Weerth, C. Faltz, D. K. Hossfeld, and S. Hegewisch-Becker. 2004. Characterization of effusion-infiltrating T cells: benign versus malignant effusions. Clin. Cancer Res. 10:2600-2608.
28. + regulatory T lymphocytes in malignant pleural effusion. Am. J. Respir. Crit. Care Med. 172:1434-1439.
29. Manel, N., D. Unutmaz, and D. R. Littman. 2008. The differentiation of human T (H)-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat. Immunol. 9:641-649.
30. Volpe, E., N. Servant, R. Zollinger, S. I. Bogiatzi, P. Hupé, E. Barillot, and V. Soumelis. 2008. A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human T (H)-17 responses. Nat. Immunol. 9:650-657.
31. Yang, L., D. E. Anderson, C. Baecher-Allan, W. D. Hastings, E. Bettelli, M. Oukka, V. K. Kuchroo, and D. A. Hafler. 2008. IL-21 and TGF-β are required for differentiation of human T (H) 17 cells. Nature 454:350-352.
32. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942-949.
33. Qin, X. J., H. Z. Shi, Z. X. Huang, L. F. Kang, W. N. Mo, and C. Wu. 2005. Interleukin-16 in tuberculous and malignant pleural effusions. Eur. Respir. J. 25:605-611.
34. Su, X., J. Ye, E. C. Hsueh, Y. Zhang, D. F. Hoft, and G. Peng. 2010. Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J. Immunol. 184:1630-1641.
35. Gocke, A. R., P. D. Cravens, L. H. Ben, R. Z. Hussain, S. C. Northrop, M. K. Racke, and A. E. Lovett-Racke. 2007. T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J. Immunol. 178:1341-1348.
36. Yang, Y., J. Weiner, Y. Liu, A. J. Smith, D. J. Huss, R. Winger, H. Peng, P. D. Cravens, M. K. Racke, and A. E. Lovett-Racke. 2009. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J. Exp. Med. 206:1549-1564.
37. Zou, W., and N. P. Restifo. 2010. T (H) 17 cells in tumour immunity and immunotherapy. Nat. Rev. Immunol. 10:248-256.
38. Martin-Orozco, N., P. Muranski, Y. Chung, X. O. Yang, T. Yamazaki, S. Lu, P. Hwu, N. P. Restifo, W. W. Overwijk, and C. Dong. 2009. T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 31:787-798.